Cinzia Cameli

Cinzia Cameli

Auto-generated profile, based on publicly available information

Cinzia Cameli

Department of Pharmacy and BioTechnology, University of Bologna, Bologna, Italy

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2015 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
EBElena Bacchelli
Elena Bacchelli
ABAgatino Battaglia
Agatino Battaglia
CCCinzia Cameli
Cinzia Cameli
SLSilvia Lomartire
Silvia Lomartire
RTRaffaella Tancredi
Raffaella Tancredi
EMElena Maestrini
Elena Maestrini

13 December 2016 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
EBElena Bacchelli
Elena Bacchelli
MCMaria Michela Cainazzo
Maria Michela Cainazzo
CCCinzia Cameli
Cinzia Cameli
SGSimona Guerzoni
Simona Guerzoni
AMAngela Martinelli
Angela Martinelli
LPLuigi-alberto Pini
Luigi-alberto Pini
Cluster Headache (CH) is a severe primary headache, with a poorly understood pathophysiology. Complex genetic factors are likely to play a role in CH etiology; however, no confirmed gene associations have been identified. The aim of this study is to identify genetic variants influencing risk to CH and to explore the potential pathogenic mechanisms. We have performed a genome-wide association study (GWAS) in a clinically well-defined cohort of 99 Italian patients with CH and in a control sample of 360 age-matched sigarette smoking healthy individuals, using the Infinium PsychArray (Illumina), which combines common highly-informative genome-wide tag SNPs and exonic SNPs. Genotype data were used to carry out a genome-wide single marker case-control association analysis using common SNPs, and a gene-based association analysis focussing on rare protein altering variants in 745 candidate genes with a putative role in CH. Although no single variant showed statistically significant association at the genome-wide threshold, we identified an interesting suggestive association (P = 9.1 × 10−6) with a common variant of the PACAP receptor gene (ADCYAP1R1). Furthermore, gene-based analysis provided significant evidence of association (P = 2.5 × 10−5) for a rare potentially damaging missense variant in the MME gene, encoding for the membrane metallo-endopeptidase neprilysin. Our study represents the first genome-wide association study of common SNPs and rare exonic variants influencing risk for CH. The most interesting results implicate ADCYAP1R1 and MME gene variants in CH susceptibility and point to a role for genes involved in pain processing. These findings provide new insights into the pathogenesis of CH that need further investigation and replication in larger CH samples.

25 February 2019 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
PDF file
TPTommaso Pippucci
Tommaso Pippucci
LLLaura Licchetta
Laura Licchetta
SBSara Baldassari
Sara Baldassari
CMCaterina Marconi
Caterina Marconi
MLMonica De Luise
Monica De Luise
TCthe Collaborative Group of Italian League Against Epilepsy (LICE) Genetic Commission
the Collaborative Group of Italian League Against Epilepsy (LICE) Genetic Commission
Objective: We investigated the contribution to sporadic focal epilepsies (FE) of ultrarare variants in genes coding for the components of complexes regulating mechanistic Target Of Rapamycin (mTOR)complex 1 (mTORC1).Methods: We collected genetic data of 121 Italian isolated FE cases and 512 controls by Whole Exome Sequencing (WES) and single‐molecule Molecular Inversion Probes (smMIPs) targeting 10 genes of the GATOR1, GATOR2, and TSC complexes. We collapsed “qualifying” variants (ultrarare and predicted to be deleterious or loss of function) across the examined genes and sought to identify their enrichment in cases compared to controls.Results: We found eight qualifying variants in cases and nine in controls, demonstrating enrichment in FE patients (P = 0.006; exact unconditional test, one‐tailed). Pathogenic variants were identified in DEPDC5 and TSC2, both major genes for Mendelian FE syndromes.Interpretation: Our findings support the contribution of ultrarare variants in genes in the mTOR pathway complexes GATOR and TSC to the risk of sporadic FE and a shared genetic basis between rare and common epilepsies. The identification of a monogenic etiology in isolated cases, most typically encountered in clinical practice, may offer to a broader community of patients the perspective of precision therapies directed by the underlying genetic cause.

7 February 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EBElena Bacchelli
Elena Bacchelli
Eleonora LoiEleonora Loi
Eleonora Loi
CCCinzia Cameli
Cinzia Cameli
LMLoredana Moi
Loredana Moi
Ana Florencia Vega-BenedettiAna Florencia Vega-Benedetti
Ana Florencia Vega-Benedetti
Patrizia ZavattariPatrizia Zavattari
Patrizia Zavattari
Autism spectrum disorders (ASDs) are a group of neurodevelopmental disorders with high heritability, although their underlying genetic factors are still largely unknown. Here we present a comprehensive genetic characterization of two ASD siblings from Sardinia by genome-wide copy number variation analysis and whole exome sequencing (WES), to identify novel genetic alterations associated with this disorder. Single nucleotide polymorphism (SNP) array data revealed a rare microdeletion involving CAPG, ELMOD3, and SH2D6 genes, in both siblings. CAPG encodes for a postsynaptic density (PSD) protein known to regulate spine morphogenesis and synaptic formation. The reduced CAPG mRNA and protein expression levels in ASD patients, in the presence of hemizygosity or a particular genetic and/or epigenetic background, highlighted the functional relevance of CAPG as a candidate gene for ASD. WES analysis led to the identification in both affected siblings of a rare frameshift mutation in VDAC3, a gene intolerant to loss of function mutation, encoding for a voltage-dependent anion channel localized on PSD. Moreover, four missense damaging variants were identified in genes intolerant to loss of function variation encoding for PSD proteins: PLXNA2, KCTD16, ARHGAP21, and SLC4A1. This study identifies CAPG and VDAC3 as candidate genes and provides additional support for genes encoding PSD proteins in ASD susceptibility.

12 February 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
MAManila Antonelli
Manila Antonelli
AFAntonio Fadda
Antonio Fadda
Eleonora LoiEleonora Loi
Eleonora Loi
LMLoredana Moi
Loredana Moi
CZCesare Zavattari
Cesare Zavattari
Patrizia ZavattariPatrizia Zavattari
Patrizia Zavattari
Integrated DNA methylation analysis identifies topographical and tumoral biomarkers in pilocytic astrocytomas Integrated DNA methylation analysis identifies topographical and tumoral biomarkers in pilocytic astrocytomas

16 October 2020 in Brain Sciences
Verified
Journal Article
Open access
PDF file
MRMagali Rochat
Magali Rochat
GDGiacomo Distefano
Giacomo Distefano
MMMonica Maffei
Monica Maffei
FTFrancesco Toni
Francesco Toni
Annio PosarAnnio Posar
Annio Posar
PVPaola Visconti
Paola Visconti
We examined the potential benefits of neuroimaging measurements across the first 5 years of life in detecting early comorbid or etiological signs of autism spectrum disorder (ASD). In particular, we analyzed the prevalence of neuroradiologic findings in routine magnetic resonance imaging (MRI) scans of a group of 117 ASD children younger than 5 years old. These data were compared to those reported in typically developing (TD) children. MRI findings in children with ASD were analyzed in relation to their cognitive level, severity of autistic symptoms, and the presence of electroencephalogram (EEG) abnormalities. The MRI was rated abnormal in 55% of children with ASD with a significant prevalence in the high-functioning subgroup compared to TD children. We report significant incidental findings of mega cisterna magna, ventricular anomalies and abnormal white matter signal intensity in ASD without significant associations between these MRI findings and EEG features. Based on these results we discuss the role that brain MRI may play in the diagnostic procedure of ASD.